Vor Biopharma Inc. (VOR) Misses Q3 EPS by 12150c

Vor Biopharma Inc. (NASDAQ: VOR) reported Q3 EPS of ($121.60), $121.50 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• James Hardie sells Fermacell unit to Holcim for €840 million
• Saba Capital funds reapprove merger plan targeting Q4 2026 close